Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash
Yuki Ichimura(Kanazawa University), Naoko Okiyama(Tokyo Medical and Dental University), Jantima Tanboon(Siriraj Hospital), Takako Miyamae(Yokohama City University Medical Center), Risa Konishi, Ryota Tanaka(University of Tsukuba), Tomohiro Morio(Tokyo Institute of Psychiatry), Masaaki Mori(Tokyo Medical and Dental University), Miwako Shobo, Akira Tamaoka(University of Tsukuba), Michio Inoue(University of Tsukuba), Ichizo Nishino(National Center of Neurology and Psychiatry), Noriko Kubota(University of Tsukuba), Asami Shimbo, Akemi Maeda, Isao Matsumoto(Kanazawa University), Akiko Ishii(University of Tsukuba), Takayuki Kishi(Yokohama City University), Sae Inoue(University of Tsukuba), Manabu Fujimoto(Osaka Gakuin University), Toshifumi Nomura, Mari Okune(University of Tsukuba)
Cited by 61
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
|Nature|2000|941
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683